![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
Learning 500 Chinese characters in 30 days is possible. |
| Obstructive Lung Diseases |
|
Free Subscription
2 Allergy |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Obstructive Lung Diseases is free of charge.
Comorbid Chronic Rhinosinusitis and Asthma: Shared Risk Factors and Treatment
Implications-An EAACI Task Force Report.
Allergy. 2026 Feb 5. doi: 10.1111/all.70237.
PubMed
Abstract available
Epithelial-Associated CD207(+) DCs Link Allergen Sensing and IL-25-Driven Th2
Inflammation in Asthma.
Allergy. 2026 Feb 2. doi: 10.1111/all.70244.
PubMed
Abstract available
Who actually has asthma? The challenge of defining and diagnosing asthma.
Ann Allergy Asthma Immunol. 2026;136:125-126.
PubMed
Lessons from the ACAAI IEI Survey: Advancing Diagnostic and Therapeutic
Strategies for the Practicing Allergist-Immunologist.
Ann Allergy Asthma Immunol. 2025 Oct 5:S1081-1206(25)01224.
PubMed
Abstract available
The Role of miR-320d in Regulation of Cigarette Smoke-Induced Pro-Inflammatory
Responses in COPD.
Arch Bronconeumol. 2026;62:86-93.
PubMed
Abstract available
New Perspectives in the Treatment of Bronchiectasis.
Arch Bronconeumol. 2026 Jan 9:S0300-2896(26)00004.
PubMed
Abstract available
Addressing the Global Challenges of COPD and Asthma: A Shared Vision from the
Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global
Initiative for Asthma (GINA).
Arch Bronconeumol. 2026;62:113-117.
PubMed
Abstract available
Difference of breath sound spectrum between healthy children and children with
cough variant asthma.
BMC Pediatr. 2026 Feb 3. doi: 10.1186/s12887-026-06546.
PubMed
Safety and efficacy of omalizumab in children aged 6 to 11 years with asthma: a
systematic review and meta-analysis of randomized controlled trials.
BMC Pediatr. 2026 Feb 7. doi: 10.1186/s12887-026-06595.
PubMed
Abstract available
Sex does not modify prediction of asthma attacks by clinical risk factors and
Type-2 biomarkers.
Chest. 2026 Jan 30:S0012-3692(26)00131-5. doi: 10.1016/j.chest.2025.
PubMed
Abstract available
Pulmonary rehabilitation in adults with asthma.
Curr Opin Pulm Med. 2026 Feb 3. doi: 10.1097/MCP.0000000000001248.
PubMed
Abstract available
Beyond phenotypic differences: integrating clinical pharmacy into precision
management of paediatric-onset bronchiectasis.
Eur Respir J. 2026;67:2501434.
PubMed
Reply to: An incomplete map: diagnostic gaps in bronchiectasis by age of onset.
Eur Respir J. 2026;67:2501810.
PubMed
An incomplete map: diagnostic gaps in bronchiectasis by age of onset.
Eur Respir J. 2026;67:2501578.
PubMed
Reply: Paediatric-onset bronchiectasis: an overlooked facet in the multifaceted
approach to bronchiectasis.
Eur Respir J. 2026;67:2501660.
PubMed
Age-Dependent Differences in Airway Inflammation and Function in Severe
Uncontrolled Asthma.
J Allergy Clin Immunol. 2026 Jan 30:S0091-6749(26)00068.
PubMed
Abstract available
COVID-19 infection raises respiratory type 2 inflammatory disease risk, whereas
vaccination is protective.
J Allergy Clin Immunol. 2026;157:517-524.
PubMed
Abstract available
Neonatal vitamin D status and asthma risk after age 5 years: A Danish
population-based cohort study.
Pediatr Allergy Immunol. 2026;37:e70299.
PubMed
Abstract available
Blood vitamin D levels at multiple time points and childhood asthma risk at age
5 years.
Pediatr Allergy Immunol. 2026;37:e70297.
PubMed
Abstract available
Beliefs and Behaviors Related to Physical Activity in Black Girls With Asthma.
Pediatr Pulmonol. 2026;61:e71497.
PubMed
Abstract available
Abnormal Chest Radiograph in 8-Year-Old Boy With Asthma.
Pediatr Rev. 2026;47:99-102.
PubMed
Managing obesity as a treatable trait of obstructive airway diseases.
Respir Med. 2026;252:108606.
PubMed
Abstract available
Personalizing the approach for the diagnosis of patients with concomitant Chronic
Obstructive Pulmonary Disease and Heart failure.
Respir Med. 2026;252:108628.
PubMed
Abstract available
Clinical value of vascular endothelial glycocalyx in acute exacerbation of
chronic obstructive pulmonary disease.
Respir Med. 2026;252:108622.
PubMed
Abstract available
Clinical stability under FF/UMEC/VI triple inhaled therapy: A 12-month real life
retrospective observational study.
Respir Med. 2026;252:108633.
PubMed
Abstract available
Relationships between bronchodilator responsiveness, a COPD polygenic risk score,
and COPD progression.
Respir Med. 2026;252:108636.
PubMed
Abstract available
A prospective study of maintenance treatment for COPD patients hospitalised for
severe exacerbations.
Respir Med. 2026;252:108648.
PubMed
Abstract available
A novel respiratory reactance index, frequency-dependent, and for
effort-independent assessment of COPD severity using MostGraph.
Respir Med. 2026;252:108656.
PubMed
Abstract available
Impact of carbon footprint information on inhaler prescribing intentions by
general practitioners: protocol for an online factorial randomised experiment.
Respir Med. 2026;252:108657.
PubMed
Abstract available
PA/A ratio >1 detected by CT-scan during acute exacerbation of chronic
obstructive pulmonary disease: A novel prognostic factor for long-term mortality
based on a cohort study.
Respir Med. 2026;252:108665.
PubMed
Abstract available
Evaluation of an air quality Alert-Based intervention in patients with stable
chronic obstructive pulmonary Disease: A prospective randomized controlled trial.
Respir Med. 2026;252:108668.
PubMed
Abstract available
Profiles of circulating T follicular helper (cTfh) cell subpopulations in
patients with asthma, COPD and asthma-COPD overlap (ACO).
Respir Med. 2026;253:108672.
PubMed
Abstract available
Corrigendum to "The EUFOREA pocket guide on paediatric asthma: A step forward in
patient care" [Respir. Med. (2025) 108631].
Respir Med. 2026 Jan 31:108692. doi: 10.1016/j.rmed.2026.108692.
PubMed
Genetically Predicted Associations Between Blood Cell Perturbation Responses and
Bronchiectasis Through Immune Mediation: A Mendelian Randomization Study.
Respir Med. 2026 Feb 3:108701. doi: 10.1016/j.rmed.2026.108701.
PubMed
Abstract available
The bacterial lysate OM-85 Reduces Exacerbations and Oral Corticosteroid Use in
Frequently Exacerbating Patients with T2-High Asthma: The OMREXA Real-World
Evidence Study.
Respir Med. 2026 Feb 4:108695. doi: 10.1016/j.rmed.2026.108695.
PubMed
Abstract available
Obesity and impaired muscle function in severe asthma: a cross sectional study.
Respir Med. 2026 Feb 4:108698. doi: 10.1016/j.rmed.2026.108698.
PubMed
Abstract available
Triggering mechanisms of acute thunderstorm asthma: epithelial barrier disruption
and immune dysregulation.
Respir Res. 2026 Feb 7. doi: 10.1186/s12931-026-03532.
PubMed
Abstract available
Comparative effectiveness of biologics in lung function improvement among
patients with severe asthma: a real-world study.
Respir Res. 2026 Feb 4. doi: 10.1186/s12931-026-03515.
PubMed
Airway microbiota in young people across four continents differ by country,
asthma status and inflammatory phenotype.
Thorax. 2026 Jan 30:thorax-2025-222965. doi: 10.1136/thorax-2025-222965.
PubMed
Abstract available
Thank you for your interest in scientific medicine.